Bone H, Dechert U, Jirik F, Schrader J W, Welham M J
School of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, United Kingdom.
J Biol Chem. 1997 May 30;272(22):14470-6. doi: 10.1074/jbc.272.22.14470.
The cytoplasmic tyrosine phosphatases, SHP1 and SHP2, are implicated in the control of cellular proliferation and survival. Here we demonstrate that both SHP1 and SHP2 associate with the betac subunit of the human interleukin-3 (IL-3) receptor following IL-3 stimulation and that the src homology region 2 (SH2) domains of these phosphatases mediate this interaction. Sequential immunoprecipitation analyses suggest this interaction is direct. Competition studies, using phosphotyrosine-containing peptides based on sequences surrounding key tyrosine residues within betac, suggest that phosphorylation of tyrosine 612 is the key event mediating the association of betac with SHP1 and SHP2. However, inhibition of SHP2 binding to betac, did not prevent tyrosine phosphorylation of SHP2. Interestingly, this same phosphopeptide served as a substrate for the tyrosine phosphatase activity of both SHP1 and SHP2. Binding of these protein-tyrosine phosphatases to the IL-3 receptor may regulate IL-3 signal transduction pathways, both through their catalytic activity and through the recruitment of other molecules to the receptor complex.
细胞质酪氨酸磷酸酶SHP1和SHP2参与细胞增殖和存活的调控。在此我们证明,白细胞介素-3(IL-3)刺激后,SHP1和SHP2均与人IL-3受体的βc亚基结合,且这些磷酸酶的src同源区2(SH2)结构域介导了这种相互作用。顺序免疫沉淀分析表明这种相互作用是直接的。竞争研究使用基于βc内关键酪氨酸残基周围序列的含磷酸酪氨酸肽,提示酪氨酸612的磷酸化是介导βc与SHP1和SHP2结合的关键事件。然而,抑制SHP2与βc的结合并不能阻止SHP2的酪氨酸磷酸化。有趣的是,相同的磷酸肽可作为SHP1和SHP2酪氨酸磷酸酶活性的底物。这些蛋白酪氨酸磷酸酶与IL-3受体的结合可能通过其催化活性以及通过招募其他分子至受体复合物来调节IL-3信号转导途径。